Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
Navina, an AI-powered primary care platform, is teaming up with physician enablement company Privia Health Group. The collaboration will equip Privia’s network of providers with Navina’s AI tech to ...
CAMBRIDGE, Mass., Nov. 3, 2025 /PRNewswire/ -- CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that ...
SpeechDx, supported by the ADDF's Diagnostic Accelerator, invites industry, biotech and academic leaders to create a new class of digital biomarkers SpeechDx speech and clinical data from each ...
Septerna may be yet to disclose “any meaningful clinical data,” but the biotech clearly thinks there will be investor appetite for its G protein-coupled receptors (GPCRs). The South San ...
As the push to integrate artificial intelligence and increase interoperability evolves, Clinical Architecture sees a dire need for tools that can assess the quality of healthcare data. Poor quality ...
In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...
Medication discontinuation and non-adherence are big problems for both pharmaceutical manufacturers and patients. Annually, pharmaceutical companies lose an estimated $250 billion due to medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback